Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    

Wishes Granted


The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has awarded a $3 million grant over the next three years to Vanderbilt-Ingram Cancer Center (VICC) investigators in support of VICC's drug discovery program. The grant will enable VICC researchers to pursue the development of new compounds to block the activity of cancer-causing genes and proteins that had previously been considered "undruggable."

In late August, UnitedHealthcare Community Plan of Tennessee donated $15,000 to the Jefferson Street United Merchants Partnership (JUMP) to support community revitalization and the creation of murals that depict healthy lifestyles.

Research in the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) aimed at developing innovative new treatments for schizophrenia has received a powerful assist from The William K. Warren Foundation, which recently announced it will increase its support by another $1 million as VCNDD's game-changing schizophrenia program approaches the point at which candidate drugs will be selected for testing in clinical trials. Two previous awards from the foundation have totaled $7.25 million since 2014.

Not-for-profit behavioral health provider Centerstone recently received its sixth renewal grant, totaling $6,060,000 over the next three years, from the U.S. Department of Veterans Affairs. The grant will fund the fifth through seventh years of Centerstone's Supportive Services for Veteran Families (SSVF), which aids low-income veterans and their families in transitioning to permanent housing. The SSVF team has helped address the needs of more than 3,000 veterans and their families across 40 Middle Tennessee and Southern Kentucky counties.

Vanderbilt University Medical Center has received an $11 million program project renewal grant from the NHLBI to study the genetics and underlying biological mechanisms that lead to idiopathic pulmonary fibrosis, which causes the lung tissue to become thick and stiff over time. With limited treatment options available, survival is currently three to five years after diagnosis.

Anton Reiner, PhD, and Tayebeh Pourmotabbed, PhD of the University of Tennessee Health Science Center (UTHSC) have received a $418,000 grand from NINDS to research a possible new gene therapy treatment approach for Huntington's disease (HD). In other news, the Social Security Administration recently updated the medical criteria for evaluating HD, which should make it easier for families with HD to access SSA benefits more quickly.

Fu-Ming Zhou, PhD, of UTHSC has received a grant totaling $1.66 million from the NINDS to study the role of dopamine as it relates to Parkinson's disease.


Related Articles:

Recent Articles

Clover Health Flu Shot Monitor Finds Only 61% of Nashville Seniors Have Been Immunized This Season

With flu shot rates increasing only 20% over the past month, too many older Middle Tennessee residents remain unvaccinated going into the height of flu season

Read More

Jacobs Out at Acadia

Veteran healthcare CEO Joey Jacobs is out at Acadia Healthcare following a Sunday board meeting that ousted the behavioral health giant's well-known leader.

Read More

Moving beyond Wellness to Well-Being

Increasingly, healthcare providers are expanding their focus beyond physical wellness to take a more holistic view of well-being.

Read More

Seasonal Affective Disorder: The Recurring Winter Blues Storm

In the United States, 10 to 20 percent of people have a form of the winter blues, and about half a million people suffer from winter Seasonal Affective Disorder or SAD.

Read More

Competition Levels Drop in Health Insurance Markets across 25 States

Read More

Vanderbilt Comments on Patient Error, CMS Corrective Action Plan

Following a medication error last December that resulted in a patient death, Vanderbilt University Medical Center faced scrutiny by CMS, which could have potentially impacted Medicare reimbursement. However, on Nov. 29, the federal agency accepted a corrective action plan submitted by the city's academic medical center.

Read More

Lifepoint Health And Rcch Healthcare Partners Announce Completion Of Merger

Read More

Cancer Care on the Cutting Edge

Nashville physician-scientists are helping lead the way in advancing cancer care.

Read More

The Evolution of Senior Living

The senior living industry is undergoing a makeover as baby boomers shift focus from medical-directed care to hospitality-driven services.

Read More

When Basic Science Becomes a Breakthrough

Noted immunologists joined forces at the recent International Cancer Immunotherapy Conference to discuss the importance of fostering and funding basic science.

Read More

Email Print



Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: